Molecular mechanisms regulating the defects in fragile X syndrome neurons derived from human pluripotent stem cells

Area of Science:

• Neuroscience
• Genetics
• Stem Cell Biology

Background:

• Fragile X syndrome (FXS) is a genetic disorder caused by the absence of the fragile X mental retardation protein (FMRP).
• FXS is associated with intellectual disability and developmental delays.
• Induced pluripotent stem cells (iPSCs) offer a model to study FXS in patient-derived neurons.

Purpose of the Study:

• To investigate the molecular phenotype of FXS using patient-derived iPSCs.
• To identify molecular pathways dysregulated in FXS neurons.
• To explore the role of microRNAs in FXS pathogenesis.

Main Methods:

• Generation of FXS-iPSCs from patient fibroblasts.
• Analysis of neural differentiation and gene expression in FXS-derived neurons.
• miRNA-array analysis to identify dysregulated miRNAs.
• Functional studies involving miRNA mimics to modulate gene expression.

Main Results:

• FXS-derived neurons exhibit aberrant regulation of neural differentiation and axon guidance genes controlled by REST (RE-1 silencing transcription factor).
• REST levels are elevated in FXS-derived neurons.
• Several miRNAs are dysregulated in FXS neurons, with hsa-mir-382 found to be downregulated.
• Restoring hsa-mir-382 in FXS neurons represses REST and upregulates its target genes.

Conclusions:

• FMRP, REST, and miRNAs are interconnected in the molecular pathology of FXS.
• Downregulation of hsa-mir-382 contributes to elevated REST levels and aberrant gene expression in FXS.
• This study uncovers a novel miRNA-mediated mechanism involving FMRP and REST in FXS development.